Volume 54, Issue 2, Pages (August 2008)

Slides:



Advertisements
Similar presentations
Volume 42, Issue 1, Pages 7-11 (July 2002)
Advertisements

Volume 50, Issue 3, Pages (September 2006)
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
The PSA Era is not Over for Prostate Cancer
Volume 43, Issue 5, Pages (May 2003)
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 54, Issue 6, Pages (December 2008)
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 64, Issue 1, Pages (July 2013)
Volume 50, Issue 5, Pages (November 2006)
Volume 67, Issue 6, Pages (June 2015)
Prostate Cancer Epidemic in Sight?
Volume 45, Issue 4, Pages (April 2004)
Volume 43, Issue 5, Pages (May 2003)
Cholinergic Innervation and Muscarinic Receptors in the Human Prostate
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Volume 63, Issue 1, Pages (January 2013)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Back to the Future: Introduction and Conclusions
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 51, Issue 1, Pages (January 2007)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 51, Issue 2, Pages (February 2007)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 60, Issue 1, Pages (July 2011)
Volume 56, Issue 1, Pages (July 2009)
Volume 60, Issue 4, Pages (October 2011)
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?  Bob Djavan  European.
Volume 72, Issue 3, Pages (September 2017)
Volume 52, Issue 4, Pages (October 2007)
Volume 49, Issue 6, Pages (June 2006)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 69, Issue 2, Pages (February 2016)
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Classification of Male Lower Urinary Tract Symptoms Using Mathematical Modelling and a Regression Tree Algorithm of Noninvasive Near-Infrared Spectroscopy.
Richard C. Harkaway  European Urology Supplements 
Training in Percutaneous Nephrolithotomy—A Critical Review
The Economic Costs of Overactive Bladder in Germany
Volume 46, Issue 6, Pages (December 2004)
Volume 41, Issue 2, Pages (February 2002)
Volume 50, Issue 5, Pages (November 2006)
Volume 46, Issue 5, Pages (November 2004)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 54, Issue 6, Pages (December 2008)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
How and When to Take Prostate Biopsies
European Urology is “Your” Journal
Volume 55, Issue 3, Pages (March 2009)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Martin Michel, Jean de la Rosette  European Urology Supplements 
Economic Burden of Bladder Cancer Across the European Union
Volume 52, Issue 6, Pages (December 2007)
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Volume 53, Issue 2, Pages (February 2008)
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Volume 51, Issue 2, Pages (February 2007)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Vassilios Tzortzis, Stavros Gravas, Jean J.M.C.H. de la Rosette 
Presentation transcript:

Volume 54, Issue 2, Pages 419-426 (August 2008) Age and Bladder Outlet Obstruction Are Independently Associated with Detrusor Overactivity in Patients with Benign Prostatic Hyperplasia  Matthias Oelke, Joyce Baard, Hessel Wijkstra, Jean J. de la Rosette, Udo Jonas, Klaus Höfner  European Urology  Volume 54, Issue 2, Pages 419-426 (August 2008) DOI: 10.1016/j.eururo.2008.02.017 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 Prevalence of detrusor overactivity in relation to different age groups. The y-axis shows the percent of patients with () or without () detrusor overactivity within the age group. The number of men (%) in each age group is listed at the base of the column. Patients in the older age groups had a significantly higher chance of detrusor overactivity (p=0.047, χ2-test for trend). European Urology 2008 54, 419-426DOI: (10.1016/j.eururo.2008.02.017) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 2 Prevalence of detrusor overactivity in relation to the bladder outlet obstruction grade (Schäfer class). The y-axis shows the percent of patients with () or without () detrusor overactivity within the Schäfer class. The number of men (%) in each Schäfer class is listed at the base of the column. The prevalence of detrusor overactivity increases continuously from 51.4% in Schäfer class 0 to 83.3% in Schäfer class VI (p<0.001, χ2-test for trend). European Urology 2008 54, 419-426DOI: (10.1016/j.eururo.2008.02.017) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 3 Relationship between detrusor pressure at maximum flow (Pdetqmax) and bladder filling volume at begin of involuntary detrusor contractions. With increasing bladder outlet obstruction, involuntary detrusor contractions appeared at lower bladder volumes (Spearman rank test: −0.082, p=0.017). European Urology 2008 54, 419-426DOI: (10.1016/j.eururo.2008.02.017) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 4 Relationship between detrusor pressure at maximum flow (Pdetqmax) and maximum amplitude of involuntary detrusor contractions. With increasing bladder outlet obstruction the maximum amplitude of involuntary detrusor contractions increased as well (Spearman rank test: 0.097, p=0.006). European Urology 2008 54, 419-426DOI: (10.1016/j.eururo.2008.02.017) Copyright © 2008 European Association of Urology Terms and Conditions